Assistant Professor; Director Pulmonary Vascular Program, Pulmonary, Critical Care & Sleep Medicine
Pulmonary Vascular Disease Program
The Pulmonary Vascular Disease Program (PVDP) at Yale (previously called Pulmonary Hypertension Center) addresses the complex needs of patients suffering from pulmonary hypertension. As a regional tertiary care referral center, the PVDP Program fosters important and timely collaborative interactions with other internationally renowned Yale specialists to provide the most comprehensive pulmonary hypertension care in the Northeast region. This coordination of specialists is possible within the largest academic multispecialty practice in Connecticut and in New England. Patients with pulmonary hypertension also benefit from a single medical record of tests and treatment, and convenient access to compassionate and professional care and education for themselves and their family members.
Winchester Chest Clinic
Fitkin Memorial Pavilion
789 Howard Ave, 2nd Floor
New Haven, CT 06519
Appt: (203) 785-4198
Fax: (203) 737-5453
- PVD Program Team
PVD Program Team
Pulmonary Vascular Disease Program Pulmonary Hypertension Nurse Coordinator,Clinical Nurse III,CMSRN
Karelys is a Pulmonary Vascular Disease Program Pulmonary Hypertension Nurse Coordinator, she is a Clinical Nurse III, CMSRN.
Associate Professor; Leadership Committee, 3CPR Council; Director of Translational Research, Yale Pulmonary Vascular Disease Program, Internal Medicine; Co-Director of the Vascular Research T32 Training Program, Internal Medicine
Assistant Professor; Associate Director, Pulmonary Vascular Disease Program
I am a pulmonary and critical care physician who specializes in pulmonary hypertension and invasive cardiopulmonary exercise testing. I see patients for the evaluation and management of pulmonary hypertension and unexplained shortness of breath. In addition, my research focuses on using invasive testing and physiology to investigate early forms of pulmonary hypertension and causes of shortness of breath that are not otherwise explained by other testing modalities. The Pulmonary Vascular Disease Program has active research ongoing in these areas.